Synthesis, Biological Evaluation, Molecular Docking and DFT Studies of Electronically Tuned Benzylidene-Based Schiff Bases
Molecules · 2026
DOI: 10.3390/molecules31193519 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Kerem Buran und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Hamidiye Faculty of Pharmacy, University of Health Sciences, Istanbul 34668, Turkey. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Benzylidene Compounds, Antioxidants. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Inspired by the medicinally relevant stilbene scaffold, a series of six electronically tuned benzylidene-based Schiff base derivatives were designed, synthesized, and characterized by FT-IR, 1H NMR, 13C NMR, and ESI-MS analyses. The biological properties of the synthesized compounds were investigated through antioxidant, enzyme inhibitory, and antimicrobial assays, while molecular docking and density functional theory (DFT) calculations were performed to rationalize the experimental findings and structure-activity relationships. Compounds 3 and 6 exhibited the strongest antioxidant activities, particularly in ABTS, CUPRAC, FRAP, phosphomolybdenum, and metal-chelating assays. Compounds 1–3 and 5 demonstrated measurable α-glucosidase inhibitory activity, although they were less potent than acarbose, whereas compounds 1 and 2 showed the highest tyrosinase inhibition within the synthesized series. Antimicrobial evaluation revealed moderate activity across the series, with compound 3 displaying relatively higher antimicrobial activity within the synthesized series. Docking studies demonstrated favorable interactions within enzyme active sites, while DFT calculations provided insights into electronic properties and molecular reactivity. As a result, the investigated substitution patterns were associated with differences in biological activity within the synthesized series, with compound 3 showing relatively favorable activity in selected assays and warranting further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Hamidiye Faculty of Pharmacy, University of Health Sciences, Istanbul 34668, Turkey.
- Experimental Medicine Application & Research Center, Validebağ Research Park, University of Health Sciences, Istanbul 34662, Turkey.
- Department of Pharmaceutical Chemistry, Institute of Graduate Studies in Health Sciences, Istanbul University, Istanbul 34116, Turkey.
- Opticianry Program, Hamidiye Vocational School of Health Services, University of Health Sciences, Istanbul 34668, Turkey.
- Department of Pharmaceutical Microbiology, Hamidiye Faculty of Pharmacy, University of Health Sciences, Istanbul 34668, Turkey.
- Department of Phytotherapy, Hamidiye Institute of Health Sciences, University of Health Sciences, Istanbul 34668, Turkey.
ORCID-Profile: Kerem Buran, Elmas Rumeysa Yıldırım, Nazmiye Öner, Derya Doğanay, Esra Mertoğlu, Abdullahi İbrahim Uba, Gokhan Zengin
Zitieren
APA
Buran, K., Yıldırım, E. R., Öner, N., Doğanay, D., Mertoğlu, E., Uba, A. İ., & Zengin, G. (2026). Synthesis, Biological Evaluation, Molecular Docking and DFT Studies of Electronically Tuned Benzylidene-Based Schiff Bases. Molecules. https://doi.org/10.3390/molecules31193519
Vancouver
Buran K, Yıldırım ER, Öner N, Doğanay D, Mertoğlu E, Uba Aİ, et al. Synthesis, Biological Evaluation, Molecular Docking and DFT Studies of Electronically Tuned Benzylidene-Based Schiff Bases. Molecules. 2026. doi:10.3390/molecules31193519
BibTeX
@article{Buran2026,
author = {Buran, Kerem and Yıldırım, Elmas Rumeysa and Öner, Nazmiye and Doğanay, Derya and Mertoğlu, Esra and Uba, Abdullahi İbrahim and Zengin, Gokhan},
title = {Synthesis, Biological Evaluation, Molecular Docking and DFT Studies of Electronically Tuned Benzylidene-Based Schiff Bases},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31193519}
}
EUVIMED